EMD Serono appoints James Hoyes president
This article was originally published in Scrip
EMD Serono, an affiliate of Merck KGaA, has appointed James Hoyes president, as well as a member of the executive management board for Merck Serono. Mr Hoyes previously served as chief commercial officer for EMD Serono, and before joining the company served in commercial roles for Elan, Sanofi and Sterling Drug.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.